421 related articles for article (PubMed ID: 21356352)
1. Circulating tumor cells as a window on metastasis biology in lung cancer.
Hou JM; Krebs M; Ward T; Sloane R; Priest L; Hughes A; Clack G; Ranson M; Blackhall F; Dive C
Am J Pathol; 2011 Mar; 178(3):989-96. PubMed ID: 21356352
[TBL] [Abstract][Full Text] [Related]
2. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
4. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer.
Jie XX; Zhang M; Du M; Cai QQ; Cong Q; Xu CJ; Zhang XY
Transl Cancer Res; 2022 Aug; 11(8):2636-2646. PubMed ID: 36093536
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC.
Mascalchi M; Falchini M; Maddau C; Salvianti F; Nistri M; Bertelli E; Sali L; Zuccherelli S; Vella A; Matucci M; Voltolini L; Pegna AL; Luconi M; Pinzani P; Pazzagli M
J Cancer Res Clin Oncol; 2016 Jan; 142(1):195-200. PubMed ID: 26210156
[TBL] [Abstract][Full Text] [Related]
8. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.
Kallergi G; Papadaki MA; Politaki E; Mavroudis D; Georgoulias V; Agelaki S
Breast Cancer Res; 2011 Jun; 13(3):R59. PubMed ID: 21663619
[TBL] [Abstract][Full Text] [Related]
9. Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer.
Pore M; Meijer C; de Bock GH; Boersma-van Ek W; Terstappen LW; Groen HJ; Timens W; Kruyt FA; Hiltermann TJ
Clin Lung Cancer; 2016 Nov; 17(6):535-542. PubMed ID: 27363902
[TBL] [Abstract][Full Text] [Related]
10. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck.
Balasubramanian P; Lang JC; Jatana KR; Miller B; Ozer E; Old M; Schuller DE; Agrawal A; Teknos TN; Summers TA; Lustberg MB; Zborowski M; Chalmers JJ
PLoS One; 2012; 7(7):e42048. PubMed ID: 22844540
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor microemboli: Progress in molecular understanding and enrichment technologies.
Umer M; Vaidyanathan R; Nguyen NT; Shiddiky MJA
Biotechnol Adv; 2018; 36(4):1367-1389. PubMed ID: 29753882
[TBL] [Abstract][Full Text] [Related]
12. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
[TBL] [Abstract][Full Text] [Related]
13. Molecular Detection of EMT Markers in Circulating Tumor Cells from Metastatic Non-Small Cell Lung Cancer Patients: Potential Role in Clinical Practice.
Milano A; Mazzetta F; Valente S; Ranieri D; Leone L; Botticelli A; Onesti CE; Lauro S; Raffa S; Torrisi MR; Marchetti P
Anal Cell Pathol (Amst); 2018; 2018():3506874. PubMed ID: 29682444
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
[TBL] [Abstract][Full Text] [Related]
15. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps.
Na TY; Schecterson L; Mendonsa AM; Gumbiner BM
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5931-5937. PubMed ID: 32127478
[TBL] [Abstract][Full Text] [Related]
16. [A Rare Case of Extremely High Counts of EpCAM
Jiang TT; Li HP; Li YC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):711-715. PubMed ID: 35871746
[TBL] [Abstract][Full Text] [Related]
17. CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor.
Torres JA; Brito ABC; Silva VSE; Messias IM; Braun AC; Ruano APC; Buim MEC; Carraro DM; Chinen LTD
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569332
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
Hamilton G; Rath B
Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
[TBL] [Abstract][Full Text] [Related]
19. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer.
Li S; Chen Q; Li H; Wu Y; Feng J; Yan Y
Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
